Metrovacesa S.A. (LON:0HXI)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 1.57B +10.2% |
| Revenue (ttm) | 617.96M +8.5% |
| Net Income | 49.60M +257.9% |
| EPS | 0.33 +257.9% |
| Shares Out | n/a |
| PE Ratio | 31.57 |
| Forward PE | 26.08 |
| Dividend | 1.37 (11.33%) |
| Ex-Dividend Date | Dec 19, 2025 |
| Volume | 1,123 |
| Average Volume | 2,410 |
| Open | 12.00 |
| Previous Close | 11.92 |
| Day's Range | 11.86 - 12.00 |
| 52-Week Range | 8.82 - 13.30 |
| Beta | 0.71 |
| RSI | 51.80 |
| Earnings Date | Apr 29, 2026 |
About Metrovacesa
Metrovacesa S.A. operates as a real estate development company in Spain. The company develops and sells residential and commercial premises, as well as selling land. Metrovacesa S.A. was founded in 1918 and is based in Madrid, Spain. [Read more]
Financial Performance
In 2025, Metrovacesa's revenue was 708.37 million, an increase of 8.47% compared to the previous year's 653.07 million. Earnings were 56.86 million, an increase of 257.94%.
Financial numbers in EUR Financial StatementsNews
Metrovacesa Earnings Call Transcript: Q4 2025
Record 2025 results with revenue up 8% YoY, EBITDA up 74%, and net profit up 258%. Strong cash flow enabled a EUR 240 million dividend (17% yield), while a robust pre-sales backlog and disciplined land strategy support positive outlook for 2026.
Metrovacesa Earnings Call Transcript: Q2 2025
Strong H1 2025 results with EUR 133 million revenue, 22% gross margin, and robust pre-sales. Full-year guidance is reiterated, with higher margins and positive net profit expected, supported by a solid sales backlog and resilient market demand.
Metrovacesa Earnings Call Transcript: Q4 2024
Delivered 2,000 units in 2024, achieving record revenues of €660 million and a net profit of €16 million. Pre-sales and backlog remain strong, with guidance for 2025 targeting higher margins and at least €150 million in operating cash flow.
Metrovacesa Transcript: EGM 2024
The meeting approved a €0.33 per share dividend, ratified a new director, and delegated powers for execution of resolutions. Management reaffirmed its commitment to distributing operational cash flow and addressed shareholder concerns about strategy and valuation.
Metrovacesa Earnings Call Transcript: Q3 2024
Pre-sales and backlog reached record highs, with revenues up and margins above target. Cash flow and dividend guidance are reaffirmed at the high end, supported by strong market demand and new financing. Regulatory changes in Madrid and major project deliveries mark significant developments.
Metrovacesa Earnings Call Transcript: Q2 2024
Strong H1 2024 results with 42% revenue growth, record pre-sales, and improved margins. Sales backlog and coverage ratios support positive outlook, while robust Spanish market fundamentals and ESG progress underpin future growth.